|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
248,920,000 |
Market
Cap: |
20.99(B) |
Last
Volume: |
1,292,678 |
Avg
Vol: |
1,818,989 |
52
Week Range: |
$62.82 - $97.14 |
|
Level
I Sector: |
Basic Materials |
Level
II Sector: |
Chemicals |
Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 212 |
Guru Rank Value : 5.8 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile International Flavors & Fragrances is a creator and manufacturer of food, beverage, health and biosciences, scent and pharma solutions and complementary adjacent products. Co.'s business segments are: Nourish, which comprises food ingredients, flavor compounds, and savory solutions and inclusions; Health and Biosciences, which comprises a portfolio of enzymes, food cultures, probiotics and other ingredients for food, home and personal care, and health and wellness applications; Scent, which creates fragrance compounds, fragrance ingredients and cosmetic ingredients and personal care products; and Pharma Solutions, which produces cellulosics and seaweed-based pharma excipients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
1,972 |
13,231 |
Total Sell Value |
$0 |
$0 |
$170,282 |
$1,580,339 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
1 |
4 |
End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Costa Mark J |
Director |
|
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
468 |
468 |
|
- |
|
Bruno Barry A. |
Director |
|
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,245 |
1,534 |
|
- |
|
Hu Gaoxiang |
Director |
|
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
434 |
434 |
|
- |
|
Willoughby Dawn C |
Director |
|
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
434 |
434 |
|
- |
|
Gold Christinia A |
Director |
|
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,245 |
9,169 |
|
- |
|
Yep Gregory L |
EVP, Chief Scientific Officer |
|
2023-04-06 |
4 |
D |
$91.45 |
$67,033 |
D/D |
(733) |
5,768 |
|
- |
|
Yep Gregory L |
EVP, Chief Scientific Officer |
|
2023-04-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,665 |
6,501 |
|
- |
|
Fauchon De Villeplee Christophe |
President, Scent |
|
2023-04-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,101 |
11,065 |
|
- |
|
Herriott Simon |
President Health & Biosciences |
|
2023-04-01 |
4 |
D |
$90.60 |
$41,767 |
D/D |
(461) |
6,433 |
|
- |
|
Herriott Simon |
President Health & Biosciences |
|
2023-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,489 |
6,894 |
|
- |
|
Clyburn Frank |
Chief Executive Officer |
|
2023-03-01 |
4 |
D |
$91.64 |
$43,712 |
D/D |
(477) |
846 |
|
- |
|
Clyburn Frank |
Chief Executive Officer |
|
2023-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,323 |
1,323 |
|
- |
|
Strzelecki Angela |
President, Pharma Solutions |
|
2023-02-19 |
4 |
D |
$96.13 |
$16,919 |
D/D |
(176) |
6,077 |
|
- |
|
Strzelecki Angela |
President, Pharma Solutions |
|
2023-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
584 |
6,253 |
|
- |
|
Herriott Simon |
President Health & Biosciences |
|
2023-02-19 |
4 |
D |
$96.13 |
$17,015 |
D/D |
(177) |
5,368 |
|
- |
|
Herriott Simon |
President Health & Biosciences |
|
2023-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
617 |
5,545 |
|
- |
|
Johnson Jennifer Amy |
EVP, General Counsel |
|
2023-02-19 |
4 |
D |
$96.13 |
$28,166 |
D/D |
(293) |
4,418 |
|
- |
|
Johnson Jennifer Amy |
EVP, General Counsel |
|
2023-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
708 |
4,711 |
|
- |
|
Ducker Michael L |
Director |
|
2023-01-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,210 |
9,878 |
|
- |
|
Strzelecki Angela |
President, Pharma Solutions |
|
2023-01-03 |
4 |
D |
$105.64 |
$51,447 |
D/D |
(487) |
5,669 |
|
- |
|
Strzelecki Angela |
President, Pharma Solutions |
|
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,341 |
6,156 |
|
- |
|
Fauchon De Villeplee Christophe |
President, Scent |
|
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
784 |
8,964 |
|
- |
|
Fortanet Francisco |
EVP, Operations |
|
2023-01-03 |
4 |
D |
$103.11 |
$229,832 |
D/D |
(2,229) |
20,263 |
|
- |
|
Fortanet Francisco |
EVP, Operations |
|
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,254 |
22,492 |
|
- |
|
Johnson Jennifer Amy |
EVP, General Counsel |
|
2022-11-01 |
4 |
D |
$95.45 |
$35,889 |
D/D |
(376) |
4,003 |
|
- |
|
717 Records found
|
|
Page 2 of 29 |
|
|